Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model

被引:114
作者
Insinga, Ralph P. [1 ]
Dasbach, Erik J. [1 ]
Elbasha, Elamin H. [1 ]
机构
[1] Merck Res Labs, Dept Hlth Econ Stat, N Wales, PA USA
关键词
CERVICAL INTRAEPITHELIAL NEOPLASIA; HIGH-RISK HPV; POLYMERASE-CHAIN-REACTION; ATYPICAL SQUAMOUS CELLS; LARGE LOOP EXCISION; SELF-REPORTED DATA; COST-EFFECTIVENESS; TRANSFORMATION ZONE; YOUNG-WOMEN; FOLLOW-UP;
D O I
10.1186/1471-2334-9-119
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Natural history models of human papillomavirus (HPV) infection and disease have been used in a number of policy evaluations of technologies to prevent and screen for HPV disease (e. g., cervical cancer, anogenital warts), sometimes with wide variation in values for epidemiologic and clinical inputs. The objectives of this study are to: (1) Provide an updated critical and systematic review of the evidence base to support epidemiologic and clinical modeling of key HPV disease-related parameters in the context of an HPV multi-type disease transmission model which we have applied within a U. S. population context; (2) Identify areas where additional studies are particularly needed. Methods: Consistent with our and other prior HPV natural history models, the literature review was confined to cervical disease and genital warts. Between October 2005 and January 2006, data were gathered from the published English language medical literature through a search of the PubMed database and references were examined from prior HPV natural history models and review papers. Study design and data quality from individual studies were compared and analyses meeting pre-defined criteria were selected. Results: Published data meeting review eligibility criteria were most plentiful for natural history parameters relating to the progression and regression of cervical intraepithelial neoplasia (CIN) without HPV typing, and data concerning the natural history of HPV disease due to specific HPV types were often lacking. Epidemiologic evidence to support age-dependency in the risk of progression and regression of HPV disease was found to be weak, and an alternative hypothesis concerning the time-dependence of transition rates is explored. No data were found on the duration of immunity following HPV infection. In the area of clinical management, data were observed to be lacking on the proportion of clinically manifest anogenital warts that are treated and the proportion of cervical cancer cases that become symptomatic by stage. Conclusion: Knowledge of the natural history of HPV disease has been considerably enhanced over the past two decades, through the publication of an increasing number of relevant studies. However, considerable opportunity remains for advancing our understanding of HPV natural history and the quality of associated models, particularly with respect to examining HPV age-and type-specific outcomes, and acquired immunity following infection.
引用
收藏
页数:26
相关论文
共 138 条
  • [1] af Geijersstam V, 1998, J INFECT DIS, V177, P1710, DOI 10.1086/517428
  • [2] Uterine cervical dysplasia and cancer:: Identification of c-myc status by quantitative polymerase chain reaction
    Aoyama, C
    Peters, J
    Senadheera, S
    Liu, P
    Shimada, H
    [J]. DIAGNOSTIC MOLECULAR PATHOLOGY, 1998, 7 (06) : 324 - 330
  • [3] EFFECT OF INTERFERON THERAPY ON HUMAN PAPILLOMAVIRUS COPY NUMBER IN PATIENTS WITH CONDYLOMA-ACUMINATUM
    ARANY, I
    RADY, P
    TYRING, SK
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1995, 310 (01) : 14 - 18
  • [4] Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: Mathematical modelling analyses
    Barnabas, Ruanne V.
    Laukkanen, Paivi
    Koskela, Pentti
    Kontula, Osmo
    Lehtinen, Matti
    Garnett, Geoff P.
    [J]. PLOS MEDICINE, 2006, 3 (05) : 624 - 632
  • [5] The role of genotype-specific human papillomavirus detection in diagnosing residual cervical intraepithelial neoplasia
    Bekkers, RLM
    Melchers, WJG
    Bakkers, JMJE
    Hanselaar, AGJM
    Quint, WGV
    Boonstra, H
    Massuger, LFAG
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (02) : 148 - 151
  • [6] Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209
  • [7] Natural history and screening model for high-risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands
    Berkhof, J
    de Bruijne, MC
    Zielinski, GD
    Meijer, CJLM
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (02) : 268 - 275
  • [8] Genital warts and their treatment
    Beutner, KR
    Wiley, DJ
    Douglas, JM
    Tyring, SK
    Fife, K
    Trofatter, K
    Stone, KM
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 : S37 - S56
  • [9] The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13 842 women
    Bigras, G
    de Marval, F
    [J]. BRITISH JOURNAL OF CANCER, 2005, 93 (05) : 575 - 581
  • [10] Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing
    Brown, AD
    Garber, AM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (04): : 347 - 353